FDA issued Complete Response Letters for the Biologics License Application for odronextamab in relapsed/refractory follicular lymphoma and in R/R diffuse large B-cell lymphoma, each after two or more lines of systemic therapy.
After a year of trying to sell his mansion, former Washington Commanders owner Daniel Snyder opted to donate it to the American Cancer Society.
The NCI Board of Scientific Advisors unanimously approved two new concepts and three reissued concepts at a meeting March 20.
Etta D. Pisano was named senior portfolio lead at the Advanced Research Projects Agency for Health.
Nirag Jhala was named chief of the Division of Oncologic Pathology at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health.
City of Hope has opened a Blood and Marrow Transplantation and Cell Therapy Program at City of Hope Cancer Center Atlanta.
A. Samer Al-Homsi, a leader in hematology, was appointed as system chief of blood and marrow transplant and cellular therapy at the Northwell Health Cancer Institute.
The Indiana University Melvin and Bren Simon Comprehensive Cancer Center will expand its lung cancer research through a $20 million gift that will advance discoveries related to lung cancer prevention, detection, and treatment and establish the Tom and Julie Wood Center for Lung Cancer Research.
Fox Chase Cancer Center opened an office in Voorhees, New Jersey. The site, which is the first that Fox Chase has opened in New Jersey, welcomes patients from within the region and beyond for treatment for urologic oncology, benign urologic conditions, plastic and reconstructive surgery, and radiation oncology consults.
The UF Health Proton Therapy Institute enhanced its playroom, a respite for its pediatric patients, significantly with innovative technology that promotes therapeutic engagement, with an 86” interactive gaming wall that features educational and sensory software.
